ROBERT FIGLIN was appointed deputy director of the Integrated Oncology Service Line at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute. Previously, he was director of the Hematology Oncology Division at the institute. In his new role, Figlin will work with clinicians and investigators to unify the health system’s approach to treating cancer.The integration of cancer...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
